Skip to main content

Month: May 2020

The Flowr Corporation Announces Partnership with Terrace Global to Fund the Development and Operations of Holigen

Flowr enters into a partnership agreement with Terrace Global to develop Flowr’s outdoor operations in Aljustrel, PortugalThe parties expect Terrace Global to fund at least C$3 million under this PartnershipTORONTO, May 14, 2020 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) announces it has entered into an Equity Line and Profit Sharing Agreement (the “Agreement” or “Partnership”) with Terrace Global Inc. (TSX.V:TRCE) (“Terrace Global”) a Canadian company focused on the development of international cannabis assets, whereby the two companies will work together to develop finished cannabis products for the European medicinal market. As part of the Partnership and under the terms of the Agreement, Terrace Global has agreed to fund the operations and certain capital expenditures at the...

Continue reading

Legacy Acquisition Corp. Announces Intent to Adjourn Special Meeting of Stockholders

Date and Time to be Announced at a Later TimeNew York, NY, May 14, 2020 (GLOBE NEWSWIRE) —  Legacy Acquisition Corp. (NYSE: “LGC”) (“Legacy”), a publicly-traded Special Purpose Acquisition Company, announced today that it intends to convene and then adjourn, without conducting any other business, Legacy’s special meeting of its stockholders (the “Special Meeting”), scheduled to occur on Monday, May 18, 2020 at 4:00 p.m., Eastern Time. The adjournment is intended to provide additional time for negotiations regarding the PIPE Financing and the terms of the Share Exchange Agreement. The date and time to reconvene the Special Meeting will be determined by Legacy’s board of directors and announced at a later time. The Special Meeting is being held to vote on the proposals described in Legacy’s definitive proxy statement, filed with the...

Continue reading

PetIQ, Inc. Announces Proposed Convertible Senior Notes Offering to Fund Capstar Acquisition

EAGLE, Idaho, May 14, 2020 (GLOBE NEWSWIRE) — PetIQ, Inc.  (“PetIQ”) (NasdaqGS: PETQ) today announced its intention to offer, subject to market and other conditions, $125,000,000 aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). PetIQ also expects to grant the initial purchasers of the notes a 30-day option to purchase up to an additional $18,750,000 principal amount of notes.The notes will be senior, unsecured obligations of PetIQ, will accrue interest payable semi-annually in arrears and will mature on June 1, 2026, unless earlier repurchased, redeemed or converted. Noteholders will have the right to convert their notes in certain circumstances and during...

Continue reading

Terra Firma Capital Corporation Reports First Quarter 2020 Financial Results

All amounts are stated in United States dollars unless otherwise indicated.Q1 2020 Financial Highlights:Revenues increased 3.0% to $4.0 millionAdjusted net income and comprehensive income(1) increased 31% to $759,000Adjusted basic and diluted earnings per share(1) increased 40% to $0.14 (CAD$0.19(2))Total Investments(3) of $130.0 millionBook Value(4) per share of $7.07 (CDN$9.94(2))Paid CDN$0.05 in quarterly dividendUpdate on COVID-19 Response:Enacted measures to protect the health and well-being of Terra Firma’s employees.Ceased all employee travel and new funding commitments.Preserving strong balance sheet and ample liquidity with $6.3 million of cash and $20.2 million of available line of credit.TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — Terra Firma Capital Corporation (TSX-V: TII) (“Terra Firma” or the “Company”),...

Continue reading

RAPT Therapeutics Reports First Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., May 14, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today reported financial results for the first quarter ended March 31, 2020 and provided an update on recent operational and business progress.“We continue to progress our programs during these challenging times. Our first priority is to protect our employees and our patients. We are practicing social distancing in the lab and conducting a good portion of our work remotely,” said Brian Wong, M.D., Ph.D., President and CEO of RAPT Therapeutics. “We remain in close contact with investigators from all of our clinical...

Continue reading

KEMET Announces Fourth Quarter and Fiscal Year Results

FORT LAUDERDALE, Fla., May 14, 2020 (GLOBE NEWSWIRE) — KEMET Corporation (the “Company”) (NYSE: KEM), a leading global supplier of electronic components, today reported preliminary results for the fourth quarter and fiscal year ended March 31, 2020.Fourth Quarter HighlightsNet sales of $293.2 millionGAAP gross margin of 31.4% and non-GAAP adjusted gross margin of 31.9%GAAP EPS net loss of $0.01 per diluted shareNon-GAAP adjusted EPS of $0.37 per diluted shareFull Year HighlightsNet sales of $1.26 billionGAAP gross margin of 33.4% and non-GAAP adjusted gross margin of 33.7%GAAP EPS of $0.70 per diluted shareNon-GAAP adjusted EPS of $2.31 per diluted share“During these unprecedented times, our number one priority remains the safety and well-being of our employees, their families, and the communities in which we operate. I am proud...

Continue reading

Conifex Announces First Quarter 2020 Results

VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) today reported results for the first quarter ended March 31, 2020.  Adjusted EBITDA* from continuing operations was positive $0.5 million for the quarter, which represented an improvement of $4.6 million over the fourth quarter of 2019, primarily attributable to increased operating earnings and lower selling, general and administrative costs. Adjusted EBITDA included softwood lumber duties expense of $2.0 million in the first quarter of 2020, 1.4 million in the last quarter of 2019 and $3.8 million in the first quarter of 2019.“With $12.1 million of cash, a largely debt-free lumber business and predictable cash flows from power generation, Conifex is well positioned to withstand the economic challenges BC lumber...

Continue reading

Sabina Gold & Silver Announces Interim Financial Results for the Quarter Ended March 31, 2020

VANCOUVER, British Columbia, May 14, 2020 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp. (“Sabina”) or (the “Company”) (SBB – TSX/ SGSVF – OTCQX) reports the interim financial results for the quarter ended March 31, 2020.“Sabina was able to advance the Back River Project on several fronts, despite slowdowns caused by COVID-19, pandemic,” said Bruce McLeod, the Company’s President & CEO.  “The Company had mobilized Goose camp for the beginning of a drill campaign to test the potential of a high-grade corridor extending up plunge from the Vault zone to the bottom of the proposed pit at Umwelt.  We were looking forward to testing this hypothesis but, out of concern for the safety of our team and our Inuit stakeholders, we elected to defer this program until later in the year. I am pleased to report that camp was demobilized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.